Wockhardt Gets Tentative Approval for Generic Allegra, FDA Says
Stock Chart for Wockhardt Ltd (WPL)
Wockhardt Ltd. (WPL), an Indian drugmaker, received tentative approval from the U.S. Food and Drug Administration for its fexofenadine hydrochloride pill, the generic version of Sanofi’s Allegra allergy medicine, according to a statement on the FDA website.
To contact the reporter on this story: Adi Narayan in Mumbai at firstname.lastname@example.org
To contact the editor responsible for this story: Niveditha Ravi at email@example.com
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.